18.08
Schlusskurs vom Vortag:
$18.41
Offen:
$18.6
24-Stunden-Volumen:
547.32K
Relative Volume:
0.96
Marktkapitalisierung:
$810.32M
Einnahmen:
$206.22M
Nettoeinkommen (Verlust:
$-16.70M
KGV:
-46.84
EPS:
-0.386
Netto-Cashflow:
$-5.55M
1W Leistung:
-2.74%
1M Leistung:
-5.64%
6M Leistung:
+37.80%
1J Leistung:
+26.35%
Si Bone Inc Stock (SIBN) Company Profile
Firmenname
Si Bone Inc
Sektor
Branche
Telefon
(408) 207-0700
Adresse
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SIBN
Si Bone Inc
|
18.08 | 833.18M | 206.22M | -16.70M | -5.55M | -0.386 |
|
ABT
Abbott Laboratories
|
97.50 | 168.71B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-06-08 | Eingeleitet | Citigroup | Buy |
| 2021-03-09 | Bestätigt | Needham | Buy |
| 2020-12-16 | Bestätigt | Needham | Buy |
| 2020-08-04 | Bestätigt | Needham | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-05 | Bestätigt | Needham | Buy |
| 2020-02-19 | Eingeleitet | Needham | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-11-12 | Eingeleitet | BofA/Merrill | Buy |
| 2018-11-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-11-12 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-11-12 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Si Bone Inc Aktie (SIBN) Neueste Nachrichten
SI-BONE receives FDA clearance for spinal fusion system By Investing.com - Investing.com Nigeria
SI-Bone stock gains after FDA clears spinal fusion system - uk.finance.yahoo.com
SI-Bone (SIBN) Gains FDA Clearance for iFuse Granite Onyx System, Expanding 3D Bone Integration Market - GuruFocus
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite - GlobeNewswire
SI-BONE: A Small Cash Milestone With Larger Implications - Orthopedics This Week
SI-BONE Announces Voluntary Recall of iFuse TORQ Implants - TipRanks
Sponsored: Overlooked Chronic Low Back Pain Cause - WFAA
Precision Trading with Si-bone Inc. (SIBN) Risk Zones - Stock Traders Daily
SI-BONE stock holds near mid-range as analysts signal upside - AD HOC NEWS
SI-BONE, Inc. (SIBN) Investor Outlook: Exploring a 38% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
SI-BONE, Inc. Stock Price Today | SIBN Live Chart & News - Traders Union
CCORF Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27 - Moomoo
SIBN: Strong growth, innovation, and reimbursement tailwinds position the business for durable expansion - TradingView
SI-BONE at Morgan Stanley conference: growth broadens beyond pelvis By Investing.com - Investing.com India
SI-BONE (NASDAQ: SIBN) Anticipates Up to $150,000 Charge from iFuse TORQ Packaging Recall - Kalkine Media
Understanding the Setup: (SIBN) and Scalable Risk - Stock Traders Daily
SI-BONE Enters Fourth Amendment To Lease On Sept 11, 2026SEC Filing - TradingView
SI-BONE (SIBN) Edges Higher: Modest Advance Above $18.60 Amid Narrow Trading RangeMAMA Signal - dars.gov.et
SIBN stock focus on SI-BONE market and fundamentals - AD HOC NEWS
Si-Bone director Jeffrey Dunn sells $378,160 of common stock By Investing.com - Investing.com South Africa
Si-Bone director Jeffrey Dunn sells $378,160 of common stock - Investing.com
SI-BONE Director Jeffrey Dunn Announces Stock Option Exercises and Sales Under 10b5-1 Plan - Kalkine Media
SI-BONE (SIBN) director exercises options, sells 20K shares - Stock Titan
SIBN Q2 2026 Earnings: 41% EPS Surprise Lifts Shares HigherEarnings Acceleration Picks - vinanet.vn
SI-BONE stock eases below 19 dollars as investors eye recent growth figures - ad-hoc-news.de
SIBN Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 41% EPS Surprise; Stock Declines 1.18% - dars.gov.et
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026 - The Manila Times
SI-BONE stock holds its latest gains as investors weigh recent revenue growth - AD HOC NEWS
Si-Bone chief op & financial officer sells $233,970 in stock - Investing.com Australia
Si-Bone CEO Laura Francis sells $522,595 in company stock - Investing.com India
Si-Bone CEO Laura Francis sells $522,595 in company stock By Investing.com - Investing.com Canada
SI-BONE Inc. (SIBN) Holds Steady at $19.57 as Shares Trade Between Key Support and Resistance LevelsRSI Oversold Picks - dars.gov.et
Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
SI-BONE officer plans $232K sale of 11,636 shares | SIBN SEC FilingForm 144 - Stock Titan
SI-BONE (NASDAQ: SIBN) trust to sell 25,972 shares under Rule 144 - Stock Titan
SI-BONE (SIBN) Financial Results: Reported EPS Tops Expectations in the Latest Reading; After Results: Shares Move 2.45% Lower at the CloseUpward Estimate Revision - siam.in
SI-BONE (SIBN) Momentum: Gains 2.46% to Reach $19.96 in Latest Trading; Level Watch: the Near-Term Reference Band Stretches From $18.96 to $20.96Corrective Wave - vinanet.vn
Si-Bone chief op & financial officer sells $337,138 in stock - Investing.com Canada
Si-Bone CEO Laura Francis sells over $1 million in company stock - Investing.com
SI-BONE (NASDAQ: SIBN) CFO sells 16,975 shares at $19.55 and $20.02 - Stock Titan
SI-BONE (SIBN) trust to sell 3,923 shares from stock units - Stock Titan
SI-BONE (NASDAQ: SIBN) insider lines up new sale after plan trades - Stock Titan
Si-Bone Insider Sold Shares Worth $337,138, According to a Recent SEC Filing - Yahoo Finance
SI-BONE (NASDAQ: SIBN) affiliate plans $110K stock sale - Stock Titan
SI-BONE (NASDAQ: SIBN) officer’s tax sale leaves 130K+ stock units - Stock Titan
SI-BONE (NASDAQ: SIBN) CFO holds 167,604 RSU shares after tax sales - Stock Titan
SI-BONE (NASDAQ: SIBN) trust to sell 51,884 shares of common stock - Stock Titan
Cadian Capital discloses 7.5% SI-BONE (SIBN) ownership in Schedule 13G filing - Stock Titan
SI-BONE (SIBN) Q2 2026 Earnings Call Transcript - AOL.com
(SIBN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
SI-BONE (STU:2K3) Shiller PE Ratio : (As of Aug. 12, 2026) - GuruFocus
Finanzdaten der Si Bone Inc-Aktie (SIBN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Si Bone Inc-Aktie (SIBN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DUNN JEFFREY W | Director |
Sep 01 '26 |
Sale |
18.91 |
20,000 |
378,160 |
16,057 |
| FRANCIS LAURA | Chief Executive Officer |
Aug 24 '26 |
Sale |
20.12 |
25,972 |
522,596 |
291,491 |
| Maheshwari Anshul | Chief Op & Financial Officer |
Aug 24 '26 |
Sale |
20.11 |
11,636 |
233,971 |
223,284 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):